Abstract:Abstract Abstract 3853 B-cell differentiation is tightly regulated by synchronized suppression and/or induction of specific transcription factors. Among them, B-cell lymphoma 6 (BCL6) and PRDM1 are considered to be master regulators for germinal center formation and terminal B-cell differentiation. Dysregulation of BCL6 and PRDM1 also have been associated with lymphomagenesis. Their regulation still need further study especially at the posttranscriptional level. Here, by using co-culture system and whole genomic microRNA microarray profiling, we show for the first time that direct B lymphoma cell-stroma cell contact between follicular dendritic cells and B-lymphocytes could induce upregulation of miR-30 family and downregulation of miR-9 and let-7 family. In silico analysis showed that miR-30s can target genes BCL6 and miR-9/let7 can target PRDM1 with direct binding sites in 3`UTR region of their mRNAs. The microarray data can be proved by microRNA specific Q-RT-PCR. Specifically, by both gain of function and loss of function studies, we functionally verified that FDCs Regulate Expression of BCL6 and PRDM1 via Cell-Cell Direct Contact induced correlated microRNA dysregulation. To further validate the direct interaction between BCL6 and miR-30, we constructed luciferase reporters containing the BCL6 3`-UTR that included miR-30 binding sites and a mutant 3`-UTR harboring mutations in the “seed pairing” sequences of the miR-30 binding site. Co-transfection of miR-30 and reporter construct into cells significantly decreased luciferase activity in wild-type but not in mutant BCL6-3`-UTR transfected cells, supporting the role of miR-30 family in the regulation of BCL6 expression. BCL6 and PRDM1 and their regulation miRNAs, let-7 and miR-30, also can be validated in primary normal B-lymphocytes and lymphoma cells by using our co-culture system. Dysregulation of BCL6 and PRDM1 is often associated with lymphomagenesis. We firstly identified that BCL6 is the direct target of miR-30 family and also verified PRDM1 is the target of miR-9, and let-7 in our system. Our studies provide a novel mechanism of post-transcriptional regulation of BCL6 and PRDM1 by several microRNAs. In the context of micro-environment, it provides a clue for germinal center B-cell differentiation as well as B-cell lymphomas progression regulated by lymphocyte cell-stroma cell contact through microRNAs. Disclosures: No relevant conflicts of interest to declare.

Follicular Dendritic Cell-Induced Microrna-Mediated Upregulation of Prdm1 and Downregulation of Bcl-6 in Non-Hodgkin'S B-Cell Lymphomas

Follicular Dendritic Cell (Fdc)-Induced Microrna-Mediated Up-Regulation of PRDM1 and Down-Regulation of BCL6 in Germinal Center B Lymphocytes: A Potential Mechanism for B-Cell Differentiation.

Microenvironment-Mediated Regulation of Micrornas in B-Lymphocytes As a Novel Mechanism for Terminal B-Cell Differentiation and Lymphomagenesis.

Follicular Dendritic Cell-Dependent Drug Resistance of Non-Hodgkin Lymphoma Involves Cell Adhesion-Mediated Bim Down-Regulation Through Induction of Microrna-181A.

Microenvironment-Mediated Bim Down-Regulation Through Induction of Microrna-181a Protects Cells from Apoptosis in Mantle-Cell and Other Non-Hodgkin B-Cell Lymphomas

Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma.

Targeting Mir-548m-HDAC6 Axis Circumvents Stroma- Mediated Drug Resistance (CAM-DR) and Clonogenicity in Non-Hodgkin B-Cell Lymphomas

Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.

A Microenvironment-Mediated C-Myc/mir-548m/hdac6 Amplification Loop in Non-Hodgkin B Cell Lymphomas.

BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population

Cd99 Triggers Upregulation Of Mir-9-Modulated Prdm1/Blimp1 In Hodgkin/Reed-Sternberg Cells And Induces Redifferentiation

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex

Advance of the relationship between PRDM1 and lymphomas

Prdm1 Is Involved In Chemoresistance Of T-Cell Lymphoma And Down-Regulated By The Proteasome Inhibitor

B-cell Receptor-Mediated NFATc1 Activation Induces IL-10/STAT3/PD-L1 Signaling in Diffuse Large B-cell Lymphoma

MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia